Frost Radar™：美國人口健康管理，2026 年

Frost Radar(TM): US Population Health Management, 2026

出版日期: 2026年07月10日 | 出版商:

Frost & Sullivan | 英文 91 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

人口健康管理 (PHM) 市場持續受益於醫療服務提供者參與基於風險的補償模式，例如聯邦醫療保險優勢計劃 (Medicare Advantage)、聯邦醫療保險共享儲蓄計劃 (Medicare Shared Savings Programs) 和其他基於價值的醫療保健合約。隨著醫療機構承擔更大的財務責任，對能夠提高醫療品質、最佳化資源利用並支持人口層面風險管理的平台的需求日益成長。醫療機構優先考慮能夠將洞察轉化為行動的解決方案。雖然分析和風險分層仍然是基本要素，但買家正在尋求能夠將護理協調、患者參與、品管和績效改進直接整合到臨床和營運工作流程中的平台。這種轉變正在加速對以工作流程為中心的 PHM 平台的需求，這些平台不僅支援報告，還支援可衡量的結果。隨著臨床、計費、配藥和社會決定因素數據的取得變得更加便捷，對整合人口健康策略的需求也不斷成長。醫療機構正在尋求能夠利用分散式資料來源的平台，以幫助他們實現對患者隨時間變化的可見性、風險調整、歸因管理以及財務績效的提升。能夠有效整合並利用支付方和醫療服務提供方生態系統資料的供應商正在獲得競爭優勢。人工智慧在醫療管理（PHM）領域的應用正從預測分析擴展到工作流程自動化、介入優先排序、診斷差距識別和護理協調。市場需求日益集中於可操作、可解釋且與工作流程整合的AI功能，這些功能能夠在維持臨床醫生監督的同時，提高生產力並支援主動式人群管理。

Frost & Sullivan公司對其所在行業的眾多公司進行分析。基於領導力及其他特徵，公司將被選中進行深入分析，並根據10項「成長」和「創新」標準進行基準評估，從而揭示其在Frost Radar™上的位置。本報告呈現每家公司在Frost Radar™上的競爭概況，並充分考慮其優勢以及最適合發揮這些優勢的機會。

Frost Radar™：兩個關鍵指標、10 個分析要素和一個平台，用於衡量未來的成長潛力。

成長指數

成長指數 (GI) 是衡量公司成長績效和結果的指標，以及公司製定和執行完全一致的成長策略和願景、強大的成長管道結構以及以市場、競爭對手和最終用戶為中心的有效銷售和行銷策略的能力。

市佔率（過去三年）
- 這是該公司過去三年在特定細分市場中與競爭對手的市場佔有率對比。
銷售成長（過去三年）
- 這顯示了過去三年中，構成Frost Radar(TM) 背景的各個市場/行業/類別中各公司的收入成長率。
成長通路
- 這可以評估公司成長通路結構的優勢和利用情況，使其能夠不斷掌握、分析和優先考慮成長機會的整體情況。
願景與策略
- 這評估的是一家公司的成長策略與其願景的契合程度。一家公司在新產品和市場方面的投資是否與其既定願景相符？
銷售與行銷
- 這衡量的是一家公司的銷售和行銷活動在多大程度上有效地刺激了需求並實現了成長目標。

創新指數

創新指數 (II) 衡量一家公司開發具有全球適用性、不斷發展和擴展以服務多個市場並符合客戶不斷變化的需求的產品、服務和解決方案的能力，而這一切都基於對顛覆性大趨勢的清晰理解。

創新的擴充性
- 此指標有助於確定組織的創新是否具有可擴展性，並在全球範圍內適用，無論是在發展中市場還是成熟市場，以及在相鄰行業和非相鄰行業。
研究與開發
- 這是一個衡量公司研發策略有效性的指標，其判斷標準是公司研發投資的規模及其對公司創新管道的貢獻。
產品系列
- 這是用於評估公司產品系列的指標，重點關注新產品對年度銷售的相對貢獻。
利用大趨勢
- 此指標用於評估公司如何積極主動地利用不斷發展的長期機會和新的經營模式，作為其創新管道的基礎。
與客戶保持一致
- 這評估一家公司的產品、服務和解決方案與現有客戶和潛在客戶的契合程度，以及不斷變化的客戶需求如何影響其創新策略。

被列入Frost Radar(TM) 的意義

Frost Radar™ 上列出的公司都是行業成長、創新或兩者兼備的領導者。這些公司在引領各自行業走向未來方面發揮著至關重要的作用。

成長潛力
- 貴公司具有巨大的未來成長潛力，因此被指定為「專注於企業」。
最佳實踐
- 貴公司在塑造產業內「成長管道™」的最佳實踐方面具有極其有利的地位。
競爭強度
- 在競爭日益激烈的環境中，貴公司是推動競爭加劇的主要力量之一。
客戶價值
- 貴公司已展現出顯著提升顧客價值提案的能力。
潛在的合作夥伴
- 對於客戶、投資者、價值鏈合作夥伴和未來人才而言，貴公司是他們首先想到的關鍵價值提供者。

策略要務與成長環境

Frost Radar™：美國人口健康管理

從企業到實際應用

Arcadia
Athenahealth
Azara Healthcare
Cedar Gate Technologies
eClinicalWorks
Epic Systems
Evolent Health
Health Catalyst
HealthEdge Software
Innovaccer
Lightbeam Health Solutions
Medecision
NextGen Healthcare
Optum
Oracle Health
ZeOmega

最佳實踐和發展機遇

Frost Radar™ 分析

下一步：利用Frost Radar™ 來增強關鍵相關人員的能力。

被列入Frost Radar(TM) 的意義
CEO成長團隊
投資者
顧客
董事會

簡介目錄

Product Code: PLWW-48

The population health management (PHM) market continues to benefit from provider participation in risk-based reimbursement models, including Medicare Advantage, the Medicare Shared Savings Program, and other value-based care arrangements. As organizations assume greater financial accountability, demand is increasing for platforms that can improve quality performance, optimize resource utilization, and support population-level risk management. Healthcare organizations are prioritizing solutions that translate insights into action. While analytics and risk stratification remain foundational, buyers are seeking platforms that embed care coordination, patient engagement, quality management, and performance improvement directly into clinical and operational workflows. This shift is accelerating demand for workflow-centric PHM platforms that support measurable outcomes rather than reporting alone. The availability of clinical, claims, pharmacy, and social determinants data is increasing the need for unified population health strategies. Organizations are seeking platforms that can activate disparate data sources to support longitudinal patient visibility, risk adjustment, attribution management, and financial performance improvement. Vendors that effectively connect and operationalize data across payer and provider ecosystems are strengthening their competitive position. AI adoption in PHM is expanding beyond predictive analytics into workflow automation, intervention prioritization, diagnosis gap identification, and care orchestration. Market demand is increasingly focused on practical, explainable, and workflow-integrated AI capabilities that improve productivity and support proactive population management while maintaining clinician oversight.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

Market Share (previous 3 years)
- This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
Revenue Growth (previous 3 years)
- This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
Growth Pipeline
- This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
Vision and Strategy
- This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
Sales and Marketing
- This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

INNOVATION SCALABILITY
- This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
RESEARCH AND DEVELOPMENT
- This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
PRODUCT PORTFOLIO
- This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
MEGATRENDS LEVERAGE
- This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
CUSTOMER ALIGNMENT
- This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

GROWTH POTENTIAL
- Your organization has significant future growth potential, which makes it a Company to Action.
BEST PRACTICES
- Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
COMPETITIVE INTENSITY
- Your organization is one of the key drivers of competitive intensity in the growth environment.
CUSTOMER VALUE
- Your organization has demonstrated the ability to significantly enhance its customer value proposition.
PARTNER POTENTIAL
- Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.